Barbara Leuchs

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 12 CIPO patents and 13 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitat Heidelberg, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2014-2025.

USPTO Granted Patents = 14 (Patent Applications = 5)

% Patents Active = 92.9

CIPO Patents = 12 (Patent Applications = 3)

EPO Patents = 13 (Patent Applications = 27)

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 14(Granted Patents)

Company Filing History:

12 out of 159

Deutsches Krebsforschungszentrum

patents

4 out of 64

Ruprecht-Karls-Universitat Heidelberg

patents

2 out of 166

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

patents

4. 2 out of 23

Ruprecht-Karls-Universitaet Heidelberg

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404498 - Optimized parvovirus H-1 production (2025-09-02),

2. 11964015 - Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor (2024-04-23),

3. 11324788 - Parvovirus formulation for treating tumors (2022-05-10),

4. 11193112 - Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles (2021-12-07),

5. 11027013 - Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor (2021-06-08),

6. 10624935 - Parvovirus formulation for treating tumors (2020-04-21),

7. 10525091 - Use of parvovirus for eliminating cancer stem cells (CSCs) (2020-01-07),

8. 10266810 - Method for large scale production and purification of parvovirus (2019-04-23),

9. 10227609 - Modified parvovirus useful for gene silencing (2019-03-12),

10. 9803219 - Adenovirus derived helper virus for enhancing recombinant parvovirus production (2017-10-31),

11. 9700588 - Use of parvovirus for eliminating cancer stem cells (CSCs) (2017-07-11),

12. 9333225 - Oncolytic virotherapy for the therapy of ewing'S sarcoma (2016-05-10),

13. 9234183 - Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid (2016-01-12),

14. 8828400 - Antibody that binds to H-1 parvovirus (2014-09-09),

Title: The Innovative Journey of Barbara Leuchs

Introduction: Barbara Leuchs, a pioneering inventor hailing from Heidelberg, Germany, has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Barbara Leuchs holds several patents in the areas of renewable energy technologies, sustainable materials, and smart devices, showcasing her versatility and forward-thinking approach to innovation.

Career Highlights: Throughout her illustrious career, Barbara Leuchs has been recognized for her innovative spirit and problem-solving abilities. Her inventions have not only revolutionized industries but have also had a positive impact on society as a whole.

Collaborations: Barbara Leuchs has collaborated with leading research institutions, universities, and tech companies to further develop and implement her inventions. Her ability to work in multidisciplinary teams has led to the successful realization of cutting-edge technologies.

Conclusion: Barbara Leuchs stands as a beacon of inspiration for aspiring inventors, especially women in the field of technology. Her dedication to innovation and commitment to creating a sustainable future through her inventions solidify her legacy as a true trailblazer in the world of inventions.